Judge Clears Feds For Withholding Generic Vancocin Docs

Law360, New York (March 19, 2012, 1:45 PM EDT) -- A Washington federal judge said Friday that federal drug regulators' withholding of information sought by ViroPharma Inc. concerning approval of laboratory testing instead of human testing for generic versions of the gastrointestinal antibiotic Vancocin was proper.

U.S. District Judge Paul L. Friedman denied ViroPharma summary judgment in its Freedom of Information Act lawsuit against the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration. He granted summary judgment to the agencies, but compelled them to supplement their declarations to establish whether...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.